Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPOR | P19235 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL841619 | 0.85 | EPOR (0.45) | EPORMEN1KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL14019315 | 0.85 | EPOR (0.45) | EPORKMT2AALDH1A1HPGD | |
| SCHEMBL841620 | 0.85 | EPOR (0.45) | EPORMEN1KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL842052 | 0.82 | EPOR (0.41) | EPORMEN1KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL842051 | 0.82 | EPOR (0.41) | EPORMEN1KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL841890 | 0.82 | HPGD (0.43) | EPORMEN1KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL841889 | 0.82 | HPGD (0.43) | EPORMEN1KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL9329177 | 0.79 | HPGD (0.50) | EPORALDH1A1MAPK1HPGDACHE | |
| SCHEMBL14044904 | 0.75 | EPOR (0.38) | EPORMEN1KMT2AALDH1A1L3MBTL1 | |
| SCHEMBL842696 | 0.75 | ATM (0.46) | EPORMEN1KMT2AALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080261923-A1 | Alkene Mimics | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080261923-A1 | Alkene Mimics | PHOSPHO1, PARN, CHAMP1 | EPOR 3209/4885MEN1 704/4885KMT2A 1204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.